CAS 23103-35-7
:Myo-Inositol Trispyrophosphate Hexasodium Salt
Description:
Myo-Inositol Trispyrophosphate Hexasodium Salt, with the CAS number 23103-35-7, is a chemical compound that serves as a derivative of inositol, a carbohydrate that plays a crucial role in cellular signaling and metabolism. This compound is characterized by its high solubility in water due to the presence of multiple sodium ions, which enhances its bioavailability. Myo-Inositol Trispyrophosphate is known for its involvement in various biological processes, including the regulation of cellular functions and signaling pathways. It acts as a signaling molecule that can influence the activity of certain enzymes and receptors. The hexasodium salt form indicates that it has six sodium ions associated with the inositol structure, which contributes to its stability and solubility. In research and therapeutic contexts, it has been studied for its potential roles in metabolic disorders and cellular signaling, making it of interest in biochemistry and pharmacology. However, specific applications and effects can vary, and further studies are often necessary to fully understand its biological implications.
Formula:C6H6Na6O21P6
Synonyms:- ITTP Hexasodium Salt
- Itpp Sodium Salt
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
myo-Inositol Trispyrophosphate Hexasodium Salt
CAS:Formula:C6H12Na6O24P6Purity:95%Color and Shape:SolidMolecular weight:791.9263myo-Inositol trispyrophosphate hexasodium salt
CAS:Formula:C6H6Na6O21P6Purity:≥ 95%Color and Shape:White to off-white powderMolecular weight:737.88myo-Inositol Trispyrophosphate Hexasodium Salt
CAS:Formula:C6H6O21P6·6NaMolecular weight:599.94 6 22.99myo-Inositol-d6 Trispyrophosphate Hexasodium Salt
CAS:Controlled Product<p>Applications Labelled myo-Inositol Trispyrophosphate hexasodium (I666020). A novel membrane-permeant allosteric effector of hemoglobin (Hb), enhances the regulated oxygen release capacity of red blood cells, thus counteracting the effects of hypoxia in diseases such as cancer and cardiovascular ailments.<br>References Duarte,C.D. et al.: Chembiochem., 11, 2543 (2010); Biolo, A. et al.: Proc. Nat. Acad. Sci. U.S.A., 106, 1926 (2009);<br></p>Formula:C6D6Na6O21P6Color and Shape:White To Light BeigeMolecular weight:743.92myo-Inositol Trispyrophosphate Hexasodium Salt
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A novel membrane-permeant allosteric effector of hemoglobin (Hb), enhances the regulated oxygen release capacity of red blood cells, thus counteracting the effects of hypoxia in diseases such as cancer and cardiovascular ailments.<br>References Duarte,C.D. et al.: Chembiochem., 11, 2543 (2010); Biolo, A. et al.: Proc. Nat. Acad. Sci. U.S.A., 106, 1926 (2009);<br></p>Formula:C6H6O21P6NaColor and Shape:NeatMolecular weight:737.88myo-Inositol trispyrophosphate hexasodium salt
CAS:Myo-Inositol trispyrophosphate (ITPP) hexasodium salt is a drug with anti-cancer properties. It is an allosteric effector that interact with hemoglobin, releasing oxygen into the target tissues to avoid hypoxia. Several studies has shown an increase on the affinity of hemoglobin to oxygen when using ITPP, fact that demonstrated it can be a good strategy for the treatment of several cardiovascular diseases.Formula:C6H6Na6O21P6Purity:Min. 95%Color and Shape:White Off-White PowderMolecular weight:737.88 g/mol




